Senators pressed NIH Director Jay Bhattacharya, MD, PhD, on proposed budget cuts that could impact the agency's pivotal research and the global standing of the American research enterprise.

A federal judge in Boston will hear arguments Monday in a lawsuit challenging the Trump administration’s legal authority to terminate billions of dollars in research grants from the National Institutes of Health.

Have we fallen so low? Have we no shame?” asked Judge William Young, in a ruling that reinstated funding to the National Institute on Minority Health and Health Disparities, among other programs.

During a Senate hearing, National Institutes of Health (NIH) Director Jayanta Bhattacharya, M.D., Ph.D., said the last few months have been “bumpy,” while underscoring Congress’ role in approving a budget and taking full responsibility for the agency’s move away from “politicized science.”

Trump's NIH cuts are gutting university labs that fuel Big Pharma's drug pipeline and pushing U.S. biotech jobs, research, and investment overseas.

The industry is facing challenges from the new administration that could have serious impacts on everything from market access, pricing, and supply chains.

Pediatric clinicians across Wisconsin are seeing the devastating consequences of policies that fail to prioritize health and well-being of children.